ProPhase Labs, Inc.
http://www.prophaselabs.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From ProPhase Labs, Inc.
Boots' Symptoms Claim For Dual Defence Not A Prevention Pitch – UK Regulator
Boots UK’s display ad for its Dual Defense cold and flu symptom nasal spray was unlikely to deceive consumers to think it could prevent infection, UK Advertising Standards Authority says, which found that text in a poster ad sufficiently "conceptualized" the claim.
Deals Shaping The Medical Industry, February 2017
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in January 2017
Cold-Eeze Deal Puts Homeopathic Brand At Center Of Mylan Consumer Business
The $50m deal adds a homeopathic brand to Mylan's portfolio that will lead its US consumer lineup; ProPhase will focus on dietary supplements; leave behind seasonal-demand products.
Mylan's Cold-Eeze OTC Acquisition Aims To Leverage Respiratory Expertise
Mylan could tap respiratory product experience to develop line extensions to the homeopathic product, now seen as the centerpiece of its US consumer business.
Company Information
- Industry
-
Pharmaceuticals
- Nutraceuticals
- OTC, Consumer
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice